Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
GETUG-AFU 31
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
- NCT03438552 ↗
- Active, not recruiting
- UNICANCER
- Focused
We haven't built an HCP commentary report on GETUG-AFU 31 (intraprostatic tumor recurrence after external radiation therapy; tests no drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on GETUG-AFU 31 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 5 |
The trial
ClinicalTrials.gov- Official title
- Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Local Recurrence of Malignant Tumor of Prostate
- Interventions
- Stereotactic Body Radiotherapy
- Arms
- SBRT at a total dose of 30 Gy · Experimental
- SBRT at a total dose of 25 Gy · Experimental
- SBRT at a total dose of 36 Gy · Experimental
- Enrollment
- 57
- Primary outcomes
- Selection of the recommended dose for salvage-SBRT (either 5 x 6 Gy, 6 x 6 Gy, or 5 x 5 Gy) based on dose-limiting toxicity observed during the 18 weeks following the initiation of salvage-SBRT.
- Estimate the efficacy of the salvage-SBRT in terms of biochemical relapse-free survival rate
- Sponsor
- UNICANCER
- Start
- Oct 18, 2018
- Primary completion
- Oct 15, 2027 (estimated)
- Results posted
- No
- Registry record
- NCT03438552 · updated Dec 20, 2024
Publications
linked from the registry- Pasquier D, Le Deley MC, Tresch E, Cormier L, Duterque M, Nenan S, Lartigau E. GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol. BMJ Open. 2019 Aug 2;9(8):e026666. doi: 10.1136/bmjopen-2018-026666. PubMed 31377694